These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 3278155)
21. Recombineering to homogeneity: extension of multiplex recombineering to large-scale genome editing. Boyle NR; Reynolds TS; Evans R; Lynch M; Gill RT Biotechnol J; 2013 May; 8(5):515-22. PubMed ID: 23436787 [TBL] [Abstract][Full Text] [Related]
22. The introduction of genes into cultured cells and intact mammals. Shapiro LJ Mead Johnson Symp Perinat Dev Med; 1983; (22):33-8. PubMed ID: 6599507 [No Abstract] [Full Text] [Related]
23. The prospective of the biotechnology industry on changing technology in pathology. Schoepke HG Arch Pathol Lab Med; 1987 Jul; 111(7):596-600. PubMed ID: 3475045 [TBL] [Abstract][Full Text] [Related]
24. Crystal gazing the new biotechnologies. Hodgson J Nat Biotechnol; 2000 Jan; 18(1):29-31. PubMed ID: 10625386 [TBL] [Abstract][Full Text] [Related]
26. Microbial systems engineering: first successes and the way ahead. Dietz S; Panke S Bioessays; 2010 Apr; 32(4):356-62. PubMed ID: 20217841 [TBL] [Abstract][Full Text] [Related]
31. Synthetic biology: exploring and exploiting genetic modularity through the design of novel biological networks. Agapakis CM; Silver PA Mol Biosyst; 2009 Jul; 5(7):704-13. PubMed ID: 19562109 [TBL] [Abstract][Full Text] [Related]
32. [Genetic engineering in modern medicine]. Viazitskiĭ PO; Volchek IA; Karginov VA; Kovalenko SP Voen Med Zh; 1990 Jan; (1):37-41. PubMed ID: 2188419 [No Abstract] [Full Text] [Related]
33. [Techniques, strategies, and uses of molecular biology in medicine]. Cerezo Román J; Madrid Marina V Rev Invest Clin; 1995; 47(6):487-98. PubMed ID: 8850149 [TBL] [Abstract][Full Text] [Related]
34. In the fast lane: large-scale bacterial genome engineering. Fehér T; Burland V; Pósfai G J Biotechnol; 2012 Jul; 160(1-2):72-9. PubMed ID: 22406111 [TBL] [Abstract][Full Text] [Related]
35. [Biotechnology for rheumatology researches]. Yamamoto K Nihon Rinsho; 1992 Mar; 50(3):468-72. PubMed ID: 1588733 [TBL] [Abstract][Full Text] [Related]
36. [Production of antibodies with the aid of genetic technology]. Hammarström L; Smith E Nord Med; 1990; 105(1):13-5, 23. PubMed ID: 2300434 [TBL] [Abstract][Full Text] [Related]
37. From yeast genetics to biotechnology. Maráz A Acta Microbiol Immunol Hung; 2002; 49(4):483-91. PubMed ID: 12512257 [TBL] [Abstract][Full Text] [Related]
38. Engineered antibodies take center stage. Huston JS; George AJ Hum Antibodies; 2001; 10(3-4):127-42. PubMed ID: 11847424 [TBL] [Abstract][Full Text] [Related]
39. Biopharmaceuticals in China. Hu X; Ma Q; Zhang S Biotechnol J; 2006 Nov; 1(11):1215-24. PubMed ID: 17089435 [TBL] [Abstract][Full Text] [Related]
40. [Progress in gene synthesis technology]. Feng M; Wang L; Tian J Sheng Wu Gong Cheng Xue Bao; 2013 Aug; 29(8):1075-85. PubMed ID: 24364345 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]